Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms

• Published in: Cells (Basel, Switzerland) Vol. 11; no. 5; p. 796
• Main Authors: Shou, Jia-Wen, Shaw, Pang-Chui
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 24.02.2022; MDPI
• Subjects: Alzheimer's disease; Apoptosis; Berberine; Berberine - pharmacology; Berberine - therapeutic use; Brain research; Dopamine; Enzymes; Herbal medicine; Humans; Hypotheses; Kinases; Medicinal plants; Memory; Metabolites; Nervous System Diseases - drug therapy; Neurological diseases; Neurological disorders; Oral administration; Parkinson's disease; Peptides; Proteins; Review; Therapeutic applications; Toxicity; Traumatic brain injury; neurological disorders; berberine
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells11050796

Neurological disorders are ranked as the leading cause of disability and the second leading cause of death worldwide, underscoring an urgent necessity to develop novel pharmacotherapies. Berberine (BBR) is a well-known phytochemical isolated from a number of medicinal herbs. BBR has attracted much interest for its broad range of pharmacological actions in treating and/or managing neurological disorders. The discoveries in basic and clinical studies of the effects of BBR on neurological disorders in the last decade have provided novel evidence to support the potential therapeutical efficacies of BBR in treating neurological diseases. In this review, we summarized the pharmacological properties and therapeutic applications of BBR against neurological disorders in the last decade. We also emphasized the major pathways modulated by BBR, which provides firm evidence for BBR as a promising drug candidate for neurological disorders.